PRX-03140
Designed to treat memory loss and other symptoms, this drug from EPIX Pharmaceuticals changed the brain wave activity in trial patients. In just two weeks, they scored better on memory tests and were more engaged. One was even able to speak in full sentences again.
Available: 5 years
Flurizan
This one, now finishing clinical trials, may attack the underlying causes of the disease. From Myriad Genetics, it reduces proteins that form plaque buildup between brain cells, possibly slowing or even stopping further damage.
Available: 1 year
Researchers expect future treatments to be a combination of drugs that attack the disease at different stages, much like the current approach to fighting AIDS and cancer.


From
Advertisement 




































Your Comments
See all
...